1 Hit in 0.046 sec

The application of population based health surveys in pharmacoepidemiologic studies in Norway

Anne Elise Eggen
2009 Norsk Epidemiologi  
<strong><span style="font-family: TimesNewRomanPS-BoldMT;"><font face="TimesNewRomanPS-BoldMT"><p align="left"> </p></font></span><p align="left"><span style="font-size: x-small; font-family: TimesNewRomanPS-BoldMT;"><span style="font-size: x-small; font-family: TimesNewRomanPS-BoldMT;">ABSTRACT</span></span></p></strong><span style="font-size: x-small; font-family: TimesNewRomanPSMT;"><span style="font-size: x-small; font-family: TimesNewRomanPSMT;"><p align="left">There has been a modest
more » ... been a modest interest in pharmacoepidemiologic research in Norway, especially when considering</p><p align="left">that drugs are comprising the most common medical treatment and the health care segment with the</p><p align="left">most rapidly increasing costs in health care. There may be several explanation for the relatively low</p><p align="left">research output. One may be the generally poor access to information from issued drug prescriptions.</p><p align="left">Comprehensive population based health surveys have been carried out in Norway for many years. The</p><p align="left">health surveys have also been used as a basis for studies of drug use, and they have made it possible to</p><p align="left">collect important background information associated with drug use. However, health surveys have primarily</p><p align="left">had their origin in etiological research and the charting of major diseases in the population. Information</p><p align="left">on drug use has primarily been included as indicators of morbidity. The questions about drug use have</p><p align="left">therefore been general and covered the use of most drug groups. They have usually included both prescription</p><p align="left">and non-prescription drugs.</p><p align="left">The more recent health surveys include questions on drugs with a more focused approach. More questions</p><p align="left">are now directed towards more defined health problems and drugs.</p><p align="left">Access to individual based drug information from issued prescriptions, with the possibility of doing record</p><p align="left">linkage studies combining data from the health surveys and prescription information, may contribute</p><p>significantly to the quality of pharmacoepidemiologic research in Norway.</p></span></span>
doi:10.5324/nje.v11i1.535 fatcat:3lai6igjpzg4jke4tpilnhip7q